Cargando…
The Landscape of the Anti-Kinase Activity of the IDH1 Inhibitors
Isocitrate dehydrogenases constitute a class of enzymes that are crucial for cellular metabolism. The overexpression or mutation of isocitrate dehydrogenases are often found in leukemias, glioblastomas, lung cancers, and ductal pancreatic cancer among others. Mutation R132H, which changes the functi...
Autores principales: | Malarz, Katarzyna, Mularski, Jacek, Pacholczyk, Marcin, Musiol, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139656/ https://www.ncbi.nlm.nih.gov/pubmed/32110969 http://dx.doi.org/10.3390/cancers12030536 |
Ejemplares similares
-
Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations
por: Malarz, Katarzyna, et al.
Publicado: (2023) -
Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest
por: Malarz, Katarzyna, et al.
Publicado: (2021) -
Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatment
por: Serda, Maciej, et al.
Publicado: (2020) -
Identification and Biological Evaluation of a Water-Soluble Fullerene Nanomaterial as BTK Kinase Inhibitor
por: Malarz, Katarzyna, et al.
Publicado: (2023) -
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
por: Simonin, Mathieu, et al.
Publicado: (2021)